Lupin Rating: Neutral- USFDA clearance for Goa unit removes overhang
EPS CAGR of 21% estimated over FY21-23e; TP revised to Rs 990; ‘Neutral’ retained as valuation leaves limited upside from present levels
After almost 4.5 years of regulatory hurdles, LPC received a favourable classification (Voluntary…